jurnista 8 mg prolonged-release tablet prolonged-release tablet
janssen-cilag, belgium - hydromorphone hydrochloride - prolonged-release tablet - 8 mg
jurnista 16 mg prolonged-release tablet prolonged-release tablet
janssen-cilag, belgium - hydromorphone hydrochloride - prolonged-release tablet - 16 mg
jurnista 32 mg prolonged-release tablet prolonged-release tablet
janssen-cilag, belgium - hydromorphone hydrochloride - prolonged-release tablet - 32 mg
jurnista 64 mg prolonged-release tablet
janssen-cilag - hydromorphone hydrochloride - prolonged-release tablet - 64 mg
jurnista 8 mg tablet
janssen pharmaceutica (pty) ltd - tablet - see ingredients - each tablet contains hydromorphone hydrochloride 8,0 mg
jurnista 16 mg tablet
janssen pharmaceutica (pty) ltd - tablet - see ingredients - each tablet contains hydromorphone hydrochloride 16,0 mg
jurnista 32 mg tablet
janssen pharmaceutica (pty) ltd - tablet - see ingredients - each tablet contains hydromorphone hydrochloride 32,0 mg
jurnista 64 mg tablet
janssen pharmaceutica (pty) ltd - tablet - see ingredients - each tablet contains hydromorphone hydrochloride 64,0 mg
jurnista 4 mg tablet
janssen pharmaceutica (pty) ltd - tablet - see ingredients - each tablet contains hydromorphone hydrochloride equivalent to hydromorphone 4,0 mg
jurnista 4 mg
janssen pharmaceutica (pty) ltd - hydromorphone hydrochloride - tablets - each extended release tablet contains; hydromorphone hydrochloride 4,0 mg